AI Answers About Meniere's Disease: Model Comparison
Data Notice: AI model performance data and benchmark scores referenced in this ai answers about meniere’s disease: model comparison article reflect evaluations as of early 2026. AI capabilities evolve rapidly with each model update, and published results may differ from current versions. [ai-answers-menieres-disease]
AI Answers About Meniere’s Disease: Model Comparison
DISCLAIMER: The content in this ai answers about meniere’s disease: model comparison article is informational and educational only and does not constitute medical advice, diagnosis, or treatment. Always seek guidance from a licensed healthcare professional for medical decisions relevant to your individual health situation. [ai-answers-menieres-disease]
Meniere’s disease is a chronic inner ear disorder affecting ~approximately 200 per 100,000 people in the United States, with ~an estimated 45,500 new cases diagnosed annually. The condition typically appears between ages 40 and 60 and affects both sexes roughly equally, though some studies suggest a slight female predominance. Meniere’s disease is characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and a sense of aural fullness. The unpredictable nature of attacks can be profoundly debilitating, with ~up to 70 percent of patients reporting significant impact on their daily activities and employment.
We asked four AI models to respond to a Meniere’s disease scenario to compare their diagnostic and management guidance.
The Question We Asked
“I’m a 48-year-old man and I’ve been having episodes of severe spinning vertigo lasting 2-4 hours, with a roaring sound and fullness in my right ear. During episodes, my hearing in that ear drops noticeably. Between episodes I feel mostly normal, but I’ve noticed my right ear hearing isn’t recovering as well as it used to. I’ve had about six episodes over the past year. What is this, and can it be treated effectively?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Correct primary diagnosis | Yes | Yes | Yes | Yes |
| Explained endolymphatic hydrops | Yes | Yes | Partial | Yes |
| Discussed dietary modifications | Yes | Yes | Yes | Yes |
| Mentioned diuretic therapy | Yes | Yes | Partial | Yes |
| Discussed betahistine | Yes | Yes | No | Yes |
| Addressed hearing preservation | Yes | Yes | Partial | Yes |
| Mentioned surgical options | Yes | Partial | No | Yes |
| Discussed attack management vs. prevention | Yes | Yes | Yes | Yes |
What Each Model Got Right
GPT-4
GPT-4 correctly identified Meniere’s disease based on the classic tetrad of episodic vertigo, hearing loss, tinnitus, and aural fullness. The model explained endolymphatic hydrops as the underlying pathophysiology and discussed the progressive nature of hearing loss with successive episodes. GPT-4 provided a thorough treatment overview including low-sodium diet, diuretics like hydrochlorothiazide, betahistine, acute attack management with vestibular suppressants, and escalation options including intratympanic steroid and gentamicin injections. The model also discussed endolymphatic sac surgery and vestibular nerve section for intractable cases.
Claude 3.5
Claude 3.5 delivered the most empathetic and patient-centered response, acknowledging the anxiety and disruption that unpredictable vertigo episodes cause. The model correctly diagnosed Meniere’s disease and provided a comprehensive lifestyle modification plan including sodium restriction to ~1,500 to 2,000 mg daily, stress management, caffeine and alcohol limitation, and regular sleep schedules. Claude 3.5 discussed the concept of trigger identification and attack diaries, which are practical tools for disease management. The model addressed the progressive hearing loss concern and recommended audiometric monitoring.
Gemini
Gemini correctly identified the condition and provided a clear, accessible explanation of why the symptoms occur in episodes. The model was particularly effective at explaining how Meniere’s disease differs from other causes of vertigo, helping the patient understand why the episodic pattern with hearing involvement points to this specific diagnosis. Gemini discussed dietary sodium reduction and acute attack management with reassuring guidance about what to do during an episode.
Med-PaLM 2
Med-PaLM 2 provided the most clinically detailed response, discussing the diagnostic criteria based on AAO-HNS guidelines and the role of audiometric testing, electrocochleography, and MRI in diagnosis. The model presented a stepwise treatment algorithm: conservative management first (diet, lifestyle), medical therapy (diuretics, betahistine), interventional procedures (intratympanic injections), and finally surgical options (endolymphatic sac decompression, labyrinthectomy). Med-PaLM 2 also discussed the natural history of the disease, noting that attack frequency often decreases over time but at the cost of progressive hearing loss.
What Each Model Got Wrong or Missed
GPT-4
GPT-4 did not adequately address the psychological impact of Meniere’s disease. The unpredictable nature of attacks can cause significant anxiety, depression, and social isolation. Support resources and cognitive behavioral therapy for managing the fear of attacks are important components of comprehensive care.
Claude 3.5
Claude 3.5 provided limited discussion of surgical and interventional options. While conservative management is first-line, patients who ask about all treatment options should receive information about intratympanic injections and surgical procedures, even if they are unlikely to need them. The model also did not discuss the diagnostic workup.
Gemini
Gemini omitted betahistine, diuretics, and interventional treatments, providing a significantly incomplete treatment picture. The model also did not discuss the progressive hearing loss that typically accompanies Meniere’s disease, which is one of the patient’s specific concerns. Surgical options were not mentioned at all.
Med-PaLM 2
Med-PaLM 2 did not provide sufficient practical advice for managing acute attacks at home. Guidance on what to do during an episode, including lying still, focusing on a stationary object, and having antiemetics available, is critical information for patients who experience unpredictable attacks.
Red Flags All Models Should Mention
All AI models should flag these warning signs in the context of Meniere’s-like symptoms:
- Sudden, complete hearing loss in the affected ear requiring urgent evaluation and possible steroid treatment
- Vertigo episodes that change character, becoming constant rather than episodic
- New neurological symptoms such as headache, visual changes, or weakness suggesting a central cause
- Drop attacks (Tumarkin crises) causing sudden falls without warning, creating serious injury risk
- Bilateral symptoms developing, which occurs in ~up to 30 percent of Meniere’s patients over time
- Significant functional impairment affecting ability to work or drive safely
When to Trust AI vs. See a Doctor
When AI Information May Be Helpful
AI tools can help patients recognize that their symptom pattern is consistent with Meniere’s disease, encouraging them to seek appropriate specialist evaluation. AI can reinforce dietary and lifestyle modifications and help patients understand their treatment options to facilitate informed discussions with their ENT specialist.
When You Must See a Doctor
An otolaryngologist or neuro-otologist should evaluate and manage Meniere’s disease. Definitive diagnosis requires audiometric testing and exclusion of other conditions. Treatment selection depends on attack frequency, severity, hearing status, and impact on quality of life, all of which require professional assessment. Intratympanic injections and surgical procedures can only be performed by trained specialists. Hearing monitoring through serial audiograms is essential for tracking disease progression.
For more context on how AI handles complex medical conditions, visit our medical AI accuracy analysis.
Methodology
For this AI Answers About Meniere’s Disease: Model Comparison evaluation, we submitted the identical patient scenario to GPT-4, Claude 3 [ai-answers-menieres-disease].5 Sonnet, Gemini 1.5 Pro, and Med-PaLM 2 in March 2026. Each model received the prompt without prior conversation context. Responses were evaluated by a neuro-otologist against current AAO-HNS guidelines. Models were scored on diagnostic accuracy, treatment comprehensiveness, practical guidance, and patient communication quality.
Key Takeaways
- All four models correctly identified Meniere’s disease from the classic symptom description, demonstrating strong recognition of this characteristic clinical pattern.
- Treatment comprehensiveness varied dramatically, with Gemini covering only basic dietary modification while Med-PaLM 2 provided the full treatment algorithm through surgical options.
- The progressive hearing loss concern raised by the patient was best addressed by GPT-4 and Med-PaLM 2, while Gemini largely overlooked this important dimension.
- Claude 3.5 excelled at practical lifestyle management advice and empathetic communication, though it lacked interventional and surgical treatment detail.
- Meniere’s disease management requires specialist oversight, and AI should supplement rather than substitute for otolaryngology care.
Next Steps
If you found this comparison helpful, explore these related resources:
- Can AI Replace Your Doctor? What the Research Says
- How We Benchmark AI Responses for Conditions Like Meniere’s Disease
- How to Ask AI About Meniere’s Disease and Other Health Questions Safely
- Compare Medical AI Models Side by Side
DISCLAIMER: The content in this ai answers about meniere’s disease: model comparison article is informational and educational only and does not constitute medical advice, diagnosis, or treatment. Always seek guidance from a licensed healthcare professional for medical decisions relevant to your individual health situation. [ai-answers-menieres-disease]
About This Article
Researched and written by the MDTalks editorial team using official sources. This article is for informational purposes only and does not constitute professional advice.
Last reviewed: · Editorial policy · Report an error